Home Carboxes 183852-65-5
183852-65-5,MFCD00674204
Catalog No.:AA003851

183852-65-5 | tert-Butyl 2-(1-hydroxy-2-methoxy-2-oxoethyl)piperazine-1-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$50.00   $35.00
- +
250mg
98%
in stock  
$61.00   $43.00
- +
1g
98%
in stock  
$240.00   $168.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003851
Chemical Name:
tert-Butyl 2-(1-hydroxy-2-methoxy-2-oxoethyl)piperazine-1-carboxylate
CAS Number:
183852-65-5
Molecular Formula:
C12H22N2O4
Molecular Weight:
258.3141
MDL Number:
MFCD00674204
SMILES:
COC(=O)CC1CNCCN1C(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
312  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
1  
XLogP3:
0.3  

Downstream Synthesis Route

[1]Locationinpatent:schemeortableScheiper,Bodo;Matter,Hans;Steinhagen,Henning;Böcskei,Zsolt;Fleury,Valérie;McCort,Gary[BioorganicandMedicinalChemistryLetters,2011,vol.21,#18,p.5480-5486]

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2015/150555,2015,A1

[2]CurrentPatentAssignee:VallineSRL-WO2022/13307,2022,A1

tert-butyl4-benzyl-2-(2-methoxy-2-oxoethyl)piperazine-1-carboxylate 
  183852-65-5 

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2015/150555,2015,A1Locationinpatent:Page/Pagecolumn148

[2]CurrentPatentAssignee:VallineSRL-WO2022/13311,2022,A1Locationinpatent:Page/Pagecolumn94

[3]CurrentPatentAssignee:VallineSRL-WO2022/13307,2022,A1Locationinpatent:Page/Pagecolumn158;159

[4]CurrentPatentAssignee:VallineSRL-WO2022/13307,2022,A1Locationinpatent:Page/Pagecolumn158;159

[5]CurrentPatentAssignee:VallineSRL-WO2022/13311,2022,A1Locationinpatent:Page/Pagecolumn94

183852-65-5   
7-bromo-2-(5-(3-chlorophenyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-4-yl)-1,5-naphthyridine 
  76-05-1   
(x)C2HF3O2*C23H21ClN6O2 

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2020/188370,2020,A1Locationinpatent:Paragraph1035;1036

183852-65-5   
C24H27BrN4OSi 
 
2-4-6-5-(6-methyl-2-pyridyl)-1H-imidazol-4-yl-3-quinolylpiperazin-2-ylaceticacid 

[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2021/102468,2021,A1Locationinpatent:Paragraph226;383;384

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:183852-65-5 Molecular Formula|183852-65-5 MDL|183852-65-5 SMILES|183852-65-5 tert-Butyl 2-(1-hydroxy-2-methoxy-2-oxoethyl)piperazine-1-carboxylate